Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$375K Buy
+3,644
New +$214K ﹤0.01% 819
2021
Q1
Sell
-34,649
Closed -$1.3M 943
2020
Q4
$1.3M Sell
34,649
-28,088
-45% -$926K 0.01% 817
2020
Q3
$2.05M Buy
62,737
+11,357
+22% +$481K 0.01% 777
2020
Q2
$2.33M Sell
51,380
-34,510
-40% -$1.76M 0.01% 646
2020
Q1
$3.92M Buy
+85,890
New +$3.89M 0.03% 467

Other funds holding ATEX

Aviva's ATEX Position: Q2 2026 in Review

Aviva opened a new position in Anterix (ATEX) in Q2 2026: 3,644 shares worth $375K. The stake represents ﹤0.01% of the portfolio and ranks #819 among its holdings. This is a return to the name: Aviva previously reported a position in ATEX as recently as Q4 2020.

Aviva first reported a position in ATEX in Q1 2020 and has held it in 5 quarters since. The position peaked at $3.92M in Q1 2020. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Aviva held 3,644 shares of Anterix worth $375K as of Q2 2026.
  • Anterix was a new Aviva position in Q2 2026.
  • Anterix made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #819 holding.
  • Aviva first reported a position in Anterix in Q1 2020 and has held it in 5 quarters since.
  • Aviva's Anterix position peaked at $3.92M in Q1 2020.
  • 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.